<DOC>
<DOCNO>
EP-0001295
</DOCNO>
<TEXT>
<DATE>
19790404
</DATE>
<IPC-CLASSIFICATIONS>
C07K-7/56 C07K-5/00 C07K-5/097 C07K-7/06 A61P-5/02 C07K-1/113 C07K-14/435 A61K-38/04 C07K-1/00 C07K-7/00 C07K-14/655 C07K-14/575 <main>C07C-103/52</main> A61K-38/22 A61K-37/02 A61P-5/00 A61K-38/00 A61P-43/00 
</IPC-CLASSIFICATIONS>
<TITLE>
somatostatin-like cyclopeptides, a process for their preparation, pharmaceutical compositions containing them, and their therapeutical application.
</TITLE>
<APPLICANT>
ciba geigy agch<sep>ciba-geigy ag<sep>ciba-geigy agklybeckstrasse 1414002 baselch<sep>ciba-geigy ag  <sep>
</APPLICANT>
<INVENTOR>
kamber bruno dr<sep>rink hans<sep>sieber peter<sep>kamber, bruno, dr.<sep>rink, hans<sep>sieber, peter<sep>kamber, bruno, dr.sonnenweg 9ch-4144 arlesheimch<sep>rink, hansrebenstrasse 10ch-4125 riehench<sep>sieber, peterbachmattweg 10ch-4153 reinachch<sep>kamber, bruno, dr.<sep>rink, hans<sep>sieber, peter<sep>kamber, bruno, dr.sonnenweg 9ch-4144 arlesheimch<sep>rink, hansrebenstrasse 10ch-4125 riehench<sep>sieber, peterbachmattweg 10ch-4153 reinachch<sep>
</INVENTOR>
<ABSTRACT>
Sulfur-free cyclopeptides with somatostatin-analogous amino acid subsequences of the formula wherein R for ASN, ALA or DES-R, TRP for D-TRP or L-TRP, which may be substituted in benzene ring by halogen atoms or nitro groups, W for a benzene ring of the L -Phenylalaninrestes given given as substituately given if there was etched hydroxyl group or halogen atom or halogen atom, or for hydrogen, x for the remainder of an ω-aminon lower alken (mono or di) - carboxylic acid or the-x and y for the remainder of an ω-aminon lower alker (mono or di ) - Carboxylic acid or DES-Y, as well as acid addition salts and complexes thereof, have similar biological properties such as somatostatin and, in particular in the form of pharmaceutical preparations, for the treatment of highly conventional secretion of somatotropin, insulin and / or glucagon used. The compounds according to the invention are obtained by obtaining a corresponding linear peptide verb, wherein the ε-amino group of the lysine residue and, if desired, the hydroxyl group of the threonine residual residues are cyclized and the existing protection groups splits.
</ABSTRACT>
</TEXT>
</DOC>
